About the Authors
- Karen Liao
-
Roles Conceptualization, Formal analysis, Investigation, Writing – original draft, Writing – review & editing
* E-mail: karen.x.liao@gsk.com
Affiliation Immunogenicity Group, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- Keguan Chen
-
Roles Investigation
Affiliation Immunogenicity Group, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- Sara Brett
-
Roles Data curation
Affiliation Oncology Cell Therapy, Oncology R&D, Stevenage, United Kingdom
- Andrew Gehman
-
Roles Formal analysis
Affiliation Research Statistics, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- Ann M. Schwartz
-
Roles Methodology
Affiliation Immunogenicity Group, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- George R. Gunn
-
Roles Resources, Writing – review & editing
Affiliation Immunogenicity Group, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
- Stephen L. DeWall
-
Roles Conceptualization, Writing – review & editing
Current address: Spark Therapeutics, Philadelphia, PA, United States of America
Affiliation Immunogenicity Group, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America
Competing Interests
The authors have read the journal’s policy and declare the following competing interests: GlaxoSmithKline provided support in the form of salaries for authors: KL, KC, SB, AG, AS, GG, SD. There are no patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.